Skip to content
Disclosery

Decheng Capital Management III (Cayman), LLC

Follow

13F filer, CIK 1747821, Grand Cayman, Cayman Islands

Decheng Capital Management III (Cayman), LLC reported $318,802,329 across 25 holdings for the quarter ended 2023-06-30, in a 13F-HR filed 2023-07-28. Its ten largest share positions make up 84.89% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-23-085148

Period
2023-06-30
Reported value
$319M
Holdings
25
Top 10 weight
84.89%
New
5
Sold out
4

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ACELYRIN INCnew+1,554,417$32.5M
ROIVANT SCIENCES LTDnew+1,459,700$14.7M
PHATnew+850,000$12.2M
ZNTLadded+275,000$7.76M
BeyondSpring Inc.new+4,958,143$5.85M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SEMA4 HOLDINGS CORPreduced-3,315,325-$19.8M
PROMETHEUS BIOSCIENCES INCexited-150,000-$16.1M
BYSIexited-4,958,143-$5.55M
ATRCexited-46,259-$1.92M
Ohr Pharmaceutical Increduced-950,000-$1.76M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2023

Share positions as resolved from 13F-HR 0001104659-23-085148, largest first. % of portfolio is the value over $318,802,329, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
Alabama Power 5.20% Div Qua…Alabama Power 5.20% Div QualifQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 6,708,288 shares; 2023Q1: 6,708,288 shares; 2023Q2: 6,708,288 shares 6,708,288$69M21.63%0
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: 1,824,583 shares; 2022Q3: 1,824,583 shares; 2022Q4: 1,824,583 shares; 2023Q1: 1,824,583 shares; 2023Q2: 2,099,583 shares 2,099,583$59.2M18.58%+275,000Timeline
ACELYRIN INCACELYRIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 1,554,417 shares 1,554,417$32.5M10.19%new
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 303,984 shares; 2022Q2: 303,984 shares; 2022Q3: 359,554 shares; 2022Q4: 359,554 shares; 2023Q1: 359,554 shares; 2023Q2: 359,554 shares 359,554$20.1M6.3%0Timeline
PACBPACIFIC BIOSCIENCES CALIF INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 1,463,872 shares; 2022Q2: 1,463,872 shares; 2022Q3: 1,463,872 shares; 2022Q4: 1,463,872 shares; 2023Q1: 1,463,872 shares; 2023Q2: 1,463,872 shares 1,463,872$19.5M6.11%0Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 869,790 shares; 2022Q2: 869,790 shares; 2022Q3: 869,790 shares; 2022Q4: 869,790 shares; 2023Q1: 869,790 shares; 2023Q2: 869,790 shares 869,790$17.7M5.54%0Timeline
ILMNILLUMINA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 154,238 shares; 2022Q2: 154,238 shares; 2022Q3: 130,138 shares; 2022Q4: 80,859 shares; 2023Q1: 80,859 shares; 2023Q2: 80,859 shares 80,859$15.2M4.76%0Timeline
ROIVANT SCIENCES LTDROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 1,459,700 shares 1,459,700$14.7M4.62%new
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 850,000 shares 850,000$12.2M3.82%newTimeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: 5,529 shares; 2022Q4: 5,529 shares; 2023Q1: 27,429 shares; 2023Q2: 27,429 shares 27,429$10.7M3.35%0Timeline
HORIZON THERAPEUTICS PLCHORIZON THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: 55,400 shares; 2022Q3: 78,900 shares; 2022Q4: 78,900 shares; 2023Q1: 78,900 shares; 2023Q2: 78,900 shares 78,900$8.11M2.55%0
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 714,285 shares; 2022Q2: 714,285 shares; 2022Q3: 714,285 shares; 2022Q4: 714,285 shares; 2023Q1: 714,285 shares; 2023Q2: 714,285 shares 714,285$6.25M1.96%0Timeline
BeyondSpring Inc.BeyondSpring Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 4,958,143 shares; 2023Q1: not reported; 2023Q2: 4,958,143 shares 4,958,143$5.85M1.84%new
SEATTLE GENETICS INCSEATTLE GENETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: 23,014 shares; 2022Q4: 23,014 shares; 2023Q1: 23,014 shares; 2023Q2: 23,014 shares 23,014$4.43M1.39%0
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 210,000 shares; 2022Q2: 210,000 shares; 2022Q3: 210,000 shares; 2022Q4: 293,333 shares; 2023Q1: 293,333 shares; 2023Q2: 293,333 shares 293,333$3.62M1.14%0Timeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 526,329 shares; 2022Q2: 526,329 shares; 2022Q3: 526,329 shares; 2022Q4: 526,329 shares; 2023Q1: 526,329 shares; 2023Q2: 526,329 shares 526,329$3.6M1.13%0Timeline
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 4,447,308 shares; 2022Q2: 4,447,308 shares; 2022Q3: 4,447,308 shares; 2022Q4: 4,447,308 shares; 2023Q1: 4,447,308 shares; 2023Q2: 4,447,308 shares 4,447,308$3.34M1.05%0Timeline
HLTHQCUE HEALTH INC COM (DE)Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 8,980,909 shares; 2022Q2: 8,980,909 shares; 2022Q3: 8,980,909 shares; 2022Q4: 8,980,909 shares; 2023Q1: 8,980,909 shares; 2023Q2: 8,980,909 shares 8,980,909$3.32M1.04%0Timeline
Mersana Therapeutics IncMersana Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 904,268 shares; 2022Q2: 904,268 shares; 2022Q3: 904,268 shares; 2022Q4: 904,268 shares; 2023Q1: 904,268 shares; 2023Q2: 904,268 shares 904,268$2.98M0.93%0
AtriCure Inc.AtriCure Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 46,259 shares; 2022Q2: 46,259 shares; 2022Q3: 46,259 shares; 2022Q4: 46,259 shares; 2023Q1: not reported; 2023Q2: 46,259 shares 46,259$2.28M0.72%new
SCYXSCYNEXIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 555,555 shares; 2022Q2: 555,555 shares; 2022Q3: 555,555 shares; 2022Q4: 555,555 shares; 2023Q1: 555,555 shares; 2023Q2: 555,555 shares 555,555$1.64M0.51%0Timeline
ADICET BIO INCADICET BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 580,000 shares; 2022Q2: 580,000 shares; 2022Q3: 580,000 shares; 2022Q4: 580,000 shares; 2023Q1: 580,000 shares; 2023Q2: 505,668 shares 505,668$1.23M0.39%-74,332
Pyxis Oncology, Inc (former…Pyxis Oncology, Inc (formerly Ape…Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: 1,894,551 shares; 2022Q4: 1,894,551 shares; 2023Q1: 1,894,551 shares; 2023Q2: 1,894,551 shares 1,894,551$814K0.26%0
SEMA4 HOLDINGS CORPSEMA4 HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 3,418,929 shares; 2022Q2: 3,418,929 shares; 2022Q3: 3,418,929 shares; 2022Q4: 3,418,929 shares; 2023Q1: 3,418,929 shares; 2023Q2: 103,604 shares 103,604$617K0.19%-3,315,325
Ohr Pharmaceutical IncOhr Pharmaceutical IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 1,000,000 shares; 2022Q2: 1,000,000 shares; 2022Q3: 1,000,000 shares; 2022Q4: 1,000,000 shares; 2023Q1: 1,000,000 shares; 2023Q2: 50,000 shares 50,000$92.5K0.03%-950,000

Sold out in Q2 2023

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
PROMETHEUS BIOSCIENCES INCPROMETHEUS BIOSCIENCES INC150,000$16.1Mshares
BYSIBEYONDSPRING INC4,958,143$5.55Mshares
ATRCATRICURE INC46,259$1.92Mshares
OWLET INCOWLET INC898,400$291Kshares

How Q2 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-23-085148 base2023-07-28acceptance time not in the bulk data set